These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37236365)

  • 21. Impact of an Advanced Hybrid Closed-Loop System on Glycemic Control Throughout the Menstrual Cycle in Women with Type 1 Diabetes Prone to Hypoglycemia.
    Mesa A; Solà C; Vinagre I; Roca D; Granados M; Pueyo I; Cabré C; Conget I; Giménez M
    Diabetes Technol Ther; 2024 Sep; 26(9):667-672. PubMed ID: 38441905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Sensor-Augmented Pump Therapy with Predictive Low-Glucose Suspend Function on Glycemic Control and Patient Satisfaction in Adults and Children with Type 1 Diabetes.
    Beato-Víbora PI; Quirós-López C; Lázaro-Martín L; Martín-Frías M; Barrio-Castellanos R; Gil-Poch E; Arroyo-Díez FJ; Giménez-Álvarez M
    Diabetes Technol Ther; 2018 Nov; 20(11):738-743. PubMed ID: 30256132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective Open-Label, Single-Arm, Single-Center Follow-Up Study of the Application of the Advanced Hybrid Closed Loop System in Well-Controlled Children and Adolescents with Type 1 Diabetes.
    Seget S; Rusak E; Polanska J; Jarosz-Chobot P
    Diabetes Technol Ther; 2022 Nov; 24(11):824-831. PubMed ID: 35852811
    [No Abstract]   [Full Text] [Related]  

  • 24. "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.
    Biester T; Kordonouri O; Holder M; Remus K; Kieninger-Baum D; Wadien T; Danne T
    Diabetes Technol Ther; 2017 Mar; 19(3):173-182. PubMed ID: 28099035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real-world prospective observational single-centre study: Hybrid closed loop improves HbA1c, time-in-range and quality of life for children, young people and their carers.
    Ng SM; Katkat N; Day H; Hubbard R; Quinn M; Finnigan L
    Diabet Med; 2022 Jul; 39(7):e14863. PubMed ID: 35488481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hybrid closed-loop insulin delivery versus sensor-augmented pump therapy in children aged 6-12 years: a randomised, controlled, cross-over, non-inferiority trial.
    Kariyawasam D; Morin C; Casteels K; Le Tallec C; Sfez A; Godot C; Huneker E; Garrec N; Benhamou PY; Polak M; Charpentier G; Franc S; Beltrand J
    Lancet Digit Health; 2022 Mar; 4(3):e158-e168. PubMed ID: 35216750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hybrid closed Loop improved glucose control compared to sensor-augmented pumps in outpatients with type 1 diabetes in real-life conditions with telehealth monitoring.
    Thivolet C; Gaudilliere M; Villar Fimbel S; Bendelac N; Mestre B; Protsenko N; Brunot S; Nicolino M
    Acta Diabetol; 2022 Mar; 59(3):395-401. PubMed ID: 34725723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness and Safety of an Advanced Hybrid Closed-Loop System in Adolescents and Adults with Type 1 Diabetes Previously Treated with Continuous Subcutaneous Insulin Infusion and Flash Glucose Monitoring.
    Gros Herguido N; Amuedo S; Bellido V; López Gallardo G; Losada F; Pérez Morales A; Ruiz Trillo CA; Soto Moreno A
    Diabetes Technol Ther; 2023 Feb; 25(2):151-156. PubMed ID: 36108305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Switching from predictive low glucose suspend to advanced hybrid closed loop control: Effects on glucose control and patient reported outcomes.
    Boscari F; Ferretto S; Cavallin F; Bruttomesso D
    Diabetes Res Clin Pract; 2022 Mar; 185():109784. PubMed ID: 35183648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Comparison of Two Hybrid Closed-Loop Systems in Italian Children and Adults With Type 1 Diabetes.
    Bassi M; Teliti M; Lezzi M; Iosca A; Strati MF; Carmisciano L; d'Annunzio G; Minuto N; Maggi D
    Front Endocrinol (Lausanne); 2021; 12():802419. PubMed ID: 35116007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy.
    Danne T; Kordonouri O; Holder M; Haberland H; Golembowski S; Remus K; Bläsig S; Wadien T; Zierow S; Hartmann R; Thomas A
    Diabetes Technol Ther; 2011 Nov; 13(11):1129-34. PubMed ID: 21827318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hybrid Close-Loop Systems Versus Predictive Low-Glucose Suspend and Sensor-Augmented Pump Therapy in Patients With Type 1 Diabetes: A Single-Center Cohort Study.
    Lunati ME; Morpurgo PS; Rossi A; Gandolfi A; Cogliati I; Bolla AM; Plebani L; Vallone L; Montefusco L; Pastore I; Cimino V; Argenti S; Volpi G; Zuccotti GV; Fiorina P
    Front Endocrinol (Lausanne); 2022; 13():816599. PubMed ID: 35498423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm.
    Buckingham BA; Forlenza GP; Pinsker JE; Christiansen MP; Wadwa RP; Schneider J; Peyser TA; Dassau E; Lee JB; O'Connor J; Layne JE; Ly TT
    Diabetes Technol Ther; 2018 Apr; 20(4):257-262. PubMed ID: 29431513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hybrid Closed Loop Overcomes the Impact of Missed or Suboptimal Meal Boluses on Glucose Control in Children with Type 1 Diabetes Compared to Sensor-Augmented Pump Therapy.
    Coutant R; Bismuth E; Bonnemaison E; Dalla-Vale F; Morinais P; Perrard M; Trely J; Faure N; Bouhours-Nouet N; Levaillant L; Farret A; Storey C; Donzeau A; Poidvin A; Amsellem-Jager J; Place J; Quemener E; Hamel JF; Breton MD; Tubiana-Rufi N; Renard E
    Diabetes Technol Ther; 2023 Jun; 25(6):395-403. PubMed ID: 36927054
    [No Abstract]   [Full Text] [Related]  

  • 35. Improving glycemic control by transitioning from the MiniMed
    Kubota S; Sato A; Hosokawa M; Okubo Y; Takayama S; Kaneko A; Shimada Y; Asano Y; Sato Y; Yamazaki M; Komatsu M
    Endocr J; 2024 Oct; 71(10):955-963. PubMed ID: 38897943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of glucose profile throughout strict COVID-19 lockdown by patients with type 1 diabetes prone to hypoglycaemia using sensor-augmented pump.
    Viñals C; Mesa A; Roca D; Vidal M; Pueyo I; Conget I; Giménez M
    Acta Diabetol; 2021 Mar; 58(3):383-388. PubMed ID: 33125525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed prandial insulin boluses are an important determinant of blood glucose control and relate to fear of hypoglycemia in people with type 1 diabetes on advanced technologies.
    Annuzzi G; Triggiani R; De Angelis R; Rainone C; Corrado A; Scidà G; Lupoli R; Bozzetto L
    J Diabetes Complications; 2024 Feb; 38(2):108689. PubMed ID: 38244326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy, Safety, and Satisfaction with the Accu-Chek Insight with Diabeloop Closed-Loop System in Subjects with Type 1 Diabetes: A Multicenter Real-World Study.
    Chico A; Navas de Solís S; Lainez M; Rius F; Cuesta M
    Diabetes Technol Ther; 2023 Apr; 25(4):242-249. PubMed ID: 36724301
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of the Sensor-Augmented Pump System with the Advanced Hybrid Closed-Loop Delivery System: Quality of Life, Diabetes Distress, and Glycaemic Outcomes in a Real-Life Context.
    Benioudakis ES; Karlafti E; Kalaitzaki A; Kalpou MA; Georgiou ED; Savopoulos C; Didangelos T
    Curr Diabetes Rev; 2024; 20(3):e310523217505. PubMed ID: 37259938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes.
    Petrovski G; Al Khalaf F; Campbell J; Umer F; Almajaly D; Hamdan M; Hussain K
    Acta Diabetol; 2021 Feb; 58(2):207-213. PubMed ID: 33044604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.